Four healthcare innovations in Manchester receive funding boost

Health Innovation Manchester has awarded £165,000 to further develop four healthcare innovations and address population health changes.

This includes:

  • £40,000 for Brush DJ, an app that encourages users to brush their teeth for an effective length of time using music and aims to reduce the risk of decay.
  • £45,000 for Lucid Group for Anisys GO, a device that can rapidly establish a patient’s risk of severe disease in inflammatory bowel disease (IBD). It is designed to help community practitioners by providing data currently only available in specialist centres.
  • £49,879 for Meaningful Apps to Nurture Children (MANC), a digital project designed by Rescon Ltd has won £49,879 of funding. It will integrate Rescon’s Lincus system, which includes a self-reporting system for physical, mental and social wellbeing, to support mental early detection and prevention for children.
  • £30,408 for NHS Oldham CCG and the MyVytalCare app. The app is a personal care record hosted on the Health and Social Care Network (HSCN).

Health Innovation Manchester, the organisation responsible for accelerating proven innovation into Greater Manchester’s health and social care services, has selected the winners of the Momentum Fund with the help of a panel of representatives from patients and partners.

Richard Deed, associate director of Industry for Health Innovation Manchester, said: “This Momentum Fund call focused on the use of digital technologies in mental health and community care, and we were pleased to receive many high-quality applications. This made selecting the winners quite challenging but using a panel of relevant and commercially focused experts we were able to select a small number of diverse but successful applicants with whom we look forward to working with. As in previous rounds of innovation funds, we will be recording their impact on the local healthcare system.” 

'Four healthcare innovations in Manchester receive funding boost' has no comments

Be the first to comment this post!

Would you like to share your thoughts?

Your email address will not be published.

This site uses Akismet to reduce spam. Learn how your comment data is processed.

© 2019 Rapid Life Sciences Ltd, a Rapid News Group Company. All Rights Reserved.

Privacy policy

Terms and conditions